Pharmacology, Toxicology and Pharmaceutical Science
Alcohol Liver Disease
100%
Ethanol
87%
Liver Disease
74%
Hepatitis B
48%
Placebo
41%
Liver Injury
40%
Hepatitis B Antigen
33%
Disease
31%
Adverse Event
30%
Hepatotoxicity
29%
Liver Cirrhosis
29%
Virus Hepatitis
28%
Toxic Hepatitis
28%
Biological Marker
27%
Clinical Trial
23%
Chronic Hepatitis B
23%
Hepatitis B Virus
23%
Anakinra
23%
Isoniazid
21%
Hepatitis C
21%
Prednisone
21%
Ribavirin
20%
Recombinant Vaccine
20%
Primary Biliary Cirrhosis
20%
Hepatic Encephalopathy
19%
Prevalence
18%
Chronic Hepatitis
18%
Vaccination Policy
18%
Injury
17%
Prednisolone
17%
Acute Hepatitis
16%
End Stage Liver Disease
16%
Recombinant Hepatitis B Vaccine
16%
Randomized Clinical Trial
15%
Methyldopa
14%
Pentoxifylline
14%
Bilirubin
13%
Infection
13%
Lactulose
13%
Neomycin
13%
Hepatitis C Virus
13%
Paracetamol
13%
Liver Cell Carcinoma
13%
Cytokeratin 18
13%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
13%
Ursodeoxycholic Acid
13%
Hepatitis A
13%
Elimination
12%
K 18
11%
Chronic Hepatitis C
11%
Chronic Active Hepatitis
11%
Antivirus Agent
11%
Inflammation
10%
Jaundice
10%
Methylprednisolone
10%
Interferon
10%
Hepatitis B Antibody
9%
Chronic Liver Disease
9%
Glucocorticoid
9%
Portal Hypertension
9%
Fatty Liver
9%
Teratogenicity
8%
Acute Kidney Failure
8%
Hepatitis B(e) Antigen
8%
Liver Necrosis
8%
Alanine Aminotransferase
8%
Malaise
8%
Receptor Antagonist
7%
Clinical Study
7%
Congenital Malformation
7%
Bile Acid
7%
Aspartate Aminotransferase
7%
Ascites
7%
Fibrosis
7%
Cholestatic Hepatitis
6%
Paraldehyde
6%
Oxoacid
6%
Endemic Disease
6%
Lactobacillus
6%
Aprindine
6%
Deferoxamine
6%
Antibiotic Agent
6%
Nude Mouse
6%
Aminophenazone
6%
Lymphoproliferative Disease
6%
Occupational Exposure
6%
Bumetanide
6%
HIV
6%
Chemotherapy
6%
Recurrent Abortion
6%
Gallstone
6%
Lactobacillus rhamnosus
6%
Anorexia
6%
Interleukin 13
6%
Mouse
6%
Technetium 99m
6%
Lipoprotein X
6%
Short Term Survival
6%
Human Serum Albumin
6%
Pharmacokinetics
6%
Keyphrases
Alcoholic Hepatitis
83%
Hepatitis
81%
Alcoholic Liver Disease
68%
Liver Disease
66%
Severe Alcoholic Hepatitis
46%
Hepatitis C
28%
Alcohol
26%
Liver Transplantation
25%
Liver
24%
United States
21%
Primary Biliary Cirrhosis
20%
Racial Disparities
15%
Cirrhosis
15%
Alcoholic Cirrhosis
15%
Corticosteroid Therapy
14%
Corticosteroids
14%
Placebo
14%
Keratin 18
13%
Education Approach
13%
Portosystemic Encephalopathy
13%
Immunoglobulin Deposition
13%
Clinicopathological Pattern
13%
Orthotopic Liver Transplantation
13%
Randomized Placebo-controlled Trial
13%
Anakinra
13%
Underutilization
13%
Meta-analysis
13%
Prednisolone Treatment
12%
Prednisone
12%
Clinical Manifestations
11%
Chronic Liver Disease
11%
Transmission Route
11%
Liver Damage
11%
90-day Mortality
10%
Alcohol Use
10%
Confidence Interval
10%
Severe Hepatitis
10%
Hepatitis C Virus
10%
Acute Hepatitis
10%
Interferon-α (IFN-α)
10%
Hepatitis B
10%
Alcoholic
9%
Mesocaval Shunt
9%
Zinc
9%
Hispanic
9%
Hepatotoxicity
9%
Prognostic Factors
9%
Portal Hypertension
9%
Liver Biopsy
8%
Etiology
8%
Alcohol-induced
8%
Hepatic Venous
8%
Chronic Hepatitis
8%
α-keto Acids
8%
Natural History
8%
Ketoanalogues
7%
Alcohol Abstinence
7%
Chronic Alcoholics
7%
Stasis
7%
Severe Acute
7%
Clinical Trials
7%
Bilirubin
7%
Biochemical Tests
7%
Liver Transplant Recipients
7%
Hepatic Encephalopathy
7%
Multicenter Randomized Clinical Trial
7%
Care Plan
6%
Inorganic Mercury
6%
Penicillin Skin Testing
6%
Cholestatic Hepatitis
6%
Shunt
6%
Limonene
6%
Paraldehyde
6%
Enhanced Toxicity
6%
Trial Performance
6%
Lactobacillus GG
6%
Histopathological Features
6%
ASC Speck
6%
Isolated Hepatocytes
6%
Hepatitis Diagnosis
6%
Hepatitis B Transmission
6%
Venous Shunt
6%
Hepatic Effects
6%
Budd-Chiari Syndrome
6%
Public Health Risk
6%
Retransplantation
6%
Pancreatitis
6%
Ethanol Administration
6%
Short-term Survival
6%
Educational Program
6%
Pentoxifylline
6%
Repeat Abortion
6%
Methyldopa
6%
Risk of Death
6%
Portal Venography
6%
Hepatic Hemodynamics
6%
Chronic Hepatic Encephalopathy
6%
Lactulose
6%
Double-blind Controlled Trial
6%
Fibrosis
6%
Medicine and Dentistry
Liver Disease
84%
Liver Transplantation
54%
Alcohol Liver Disease
49%
Primary Biliary Cirrhosis
41%
Alcohol Consumption
35%
Disease
26%
Liver Injury
26%
Liver Cirrhosis
22%
Clinical Trial
22%
Hepatitis Virus
20%
Prevalence
18%
Hepatitis B Virus
16%
Alcoholic Polyneuropathy
16%
Fatty Liver
16%
Hepatitis C
15%
Biological Marker
15%
Sclerosing Cholangitis
14%
Hepatic Encephalopathy
14%
Fulminant
13%
Budd-Chiari Syndrome
13%
Liver Angiography
13%
Neomycin
13%
Lactulose
13%
Immunoglobulin Deposition
13%
Ribavirin
13%
Hepatitis B
13%
Hepatitis
13%
Hepatitis C Virus
13%
Common Hepatic Duct
11%
Liver Graft
11%
Ascites
10%
Drug Therapy
10%
Teratogenicity
9%
Liver Biopsy
9%
Infusion
9%
Catheterization
9%
Superior Mesenteric Vein
9%
Cholestasis
8%
Alcohol Abstinence
8%
Fibrosis
8%
Placebo
8%
Infection
8%
Primary Sclerosing Cholangitis
8%
Hepatitis B Antigen
8%
Public Health
8%
Awareness
8%
Corticosteroid Therapy
8%
Transaminase
8%
Immunoglobulin M
8%
Chronic Liver Disease
8%
Alcohol-Related Liver Disease
7%
Hepatology
7%
Glucocorticoid
7%
Sarcoidosis
7%
Hemodynamic
7%
Proportional Hazards Model
7%
Congenital Malformation
7%
Brain Disease
6%
Discriminant Analysis
6%
Mercurous Chloride
6%
Computer Assisted Tomography
6%
Toxic Hepatitis
6%
Antivirus Agent
6%
Limonene
6%
Chronic Hepatitis
6%
Cardiac Tamponade
6%
Cardiolipin Antibody
6%
Recurrent Abortion
6%
Internal Medicine
6%
Rheumatic Disorder
6%
Meta-Analysis
6%
Randomized Controlled Trial
6%
Mesocaval Shunt
6%
Control of Hemorrhage
6%
Pancreatitis
6%
Retransplantation
6%
Hepatobiliary Disease
6%
Glucuronosyltransferase
6%
Aeromonas
6%
Surgery
6%
Malabsorption
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Short Term Survival
6%
Alpha Tocopherol
6%
Intracranial Pressure
6%
Human Immunodeficiency Virus
6%
Interleukin 13
6%
Obstruction
6%
Portal Hypertension
6%
Vasopressin
6%
Sorbitol
6%
Interferon
6%
Wilson's Disease
6%
Health Care
6%
Alpha Tocopherol Deficiency
6%
Silastic
6%
Ethnic Disparity
6%
Racial Disparity
6%
Macrophage Activation
6%
Neoplasm
6%